Vaxcyte Catapults As It Looks To Take On Pfizer, Merck In A Massive Market
Investor's Business DailyVaxcyte shares rocketed Tuesday after the biotech company delivered “stunning” test results for its pneumococcal vaccine.
The post Vaxcyte Catapults As It Looks To Take On Pfizer, Merck In A Massive Market appeared first on Investor's Business Dai…